Company Overview and News

 
PTL Enterprises Limited - Shareholders meeting

2018-07-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - Financial Result Updates

2018-07-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - Shareholders meeting

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - Outcome of Board Meeting

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - Dividend

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - AGM/Book Closure

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - Financial Result Updates

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

34
Market Live: Sensex dips over 150 pts, Nifty breaks 10,550; rupee falls to 66.80/$, Europe down

2018-04-25 moneycontrol
2:40 pm Rupee Update: The Indian rupee extended fall to 66.80 against the US dollar, down 42 paise from previous closing of 66.38 a dollar on bouts of month-end dollar demand from importers amid crude price volatility and rising US bond yields.
500249 JIPKY ICLQY 511389 532832 533179 532960 5225 534816 UCLQY 509220 SBAZ GICHSGFIN ATFL SYNGENE 500215 VOD 532508 539268 STRTECH 511676 532822 ULTRACEMCO SRLRY 500182 FORTIS 500180 KSBPUMPS Q0F PTL IBREALEST BHRYY 512573 532538 BHRQY VIDEOIND IDBLZ 532187 INFRATEL HDFCBANK HEROMOTOCO JSL BHARTIARTL IHHHF AVANTI VOD INDUSINDBK IBVENTURES IBN UCLQF JPASSOCIAT 532843 532532 532454 ICICIBANK 532374 VODPF HDB 532174 IDEA HRTQY PERSISTENT

19
Market Live: Sensex remains weak, but IT stocks extend gain after rupee falls to 66.74/$

2018-04-25 moneycontrol
1:02 pm Economic Growth: Indian economy is expected to witness a cyclical recovery driven by investments as well as consumption, and the average GDP growth is expected to rise to 7.8 percent in the first half of this year, says a report.
BHRYY 500249 JIPKY 512573 532538 ICLQY BHRQY 532832 511389 VIDEOIND IDBLZ 532960 5225 534816 UCLQY 509220 HEROMOTOCO JSL INFRATEL BHARTIARTL IHHHF SBAZ ATFL SYNGENE 500215 VOD VOD AVANTI IBVENTURES 532508 539268 JPASSOCIAT UCLQF 532822 532843 ULTRACEMCO 532532 500182 532454 VODPF FORTIS IDEA HRTQY KSBPUMPS Q0F PTL IBREALEST

19
Market Live: Nifty below 10,600 amid consolidation; Wipro gains ahead of earnings

2018-04-25 moneycontrol
11:55 am Merger Approval: Bhageria Industries informed BSE that the National Company Law Tribunal [NCLT), Mumbai has approved the scheme of Amalgamation of Nipur Chemicals Limited with the company.
BHRYY 500249 JIPKY 512573 532538 ICLQY BHRQY 532832 IDBLZ 532960 5225 534816 UCLQY 509220 HEROMOTOCO JSL INFRATEL BHARTIARTL IHHHF SBAZ ATFL SYNGENE 500215 VOD VOD AVANTI IBVENTURES 532508 539268 JPASSOCIAT UCLQF 532822 532843 ULTRACEMCO 532532 500182 532454 VODPF FORTIS IDEA HRTQY KSBPUMPS Q0F PTL IBREALEST

 
PTL Enterprises Limited - Committee Meeting Updates

2018-04-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

 
PTL Enterprises Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509220 PTL

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to NSE:PTL / PTL ENTERPRISES LTD. on message board site Silicon Investor.

OptiSystems Solutions (OPTL) OptiSystems Solutions (OPTL) OptiSystems Solutions (OPTL) CPTL CPTL CPTL